Detalhe da pesquisa
1.
Retraction: Down-regulation of integrin αvß3 expression and integrin-mediated signaling in glioma cells by adenovirus-mediated transfer of antisense urokinase-type plasminogen activator receptor (uPAR) and sense p16 genes.
J Biol Chem
; 295(37): 13134, 2020 09 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32917827
2.
First-in-human phase I study of the OX40 agonist GSK3174998 with or without pembrolizumab in patients with selected advanced solid tumors (ENGAGE-1).
J Immunother Cancer
; 11(3)2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36927527
3.
Innate immunity as a target for novel therapeutics in triple negative breast cancer.
Expert Opin Investig Drugs
; 31(8): 781-794, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35791862
4.
Tipifarnib-induced apoptosis in acute myeloid leukemia and multiple myeloma cells depends on Ca2+ influx through plasma membrane Ca2+ channels.
J Pharmacol Exp Ther
; 337(3): 636-43, 2011 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-21378206
5.
Belantamab Mafodotin (GSK2857916) Drives Immunogenic Cell Death and Immune-mediated Antitumor Responses In Vivo.
Mol Cancer Ther
; 20(10): 1941-1955, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34253590
6.
High OX-40 expression in the tumor immune infiltrate is a favorable prognostic factor of overall survival in non-small cell lung cancer.
J Immunother Cancer
; 7(1): 351, 2019 12 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-31843013
7.
Anti-OX40 Antibody Directly Enhances The Function of Tumor-Reactive CD8+ T Cells and Synergizes with PI3Kß Inhibition in PTEN Loss Melanoma.
Clin Cancer Res
; 25(21): 6406-6416, 2019 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31371342
8.
Radiation Followed by OX40 Stimulation Drives Local and Abscopal Antitumor Effects in an Anti-PD1-Resistant Lung Tumor Model.
Clin Cancer Res
; 24(22): 5735-5743, 2018 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29784675
9.
Tumor-immune profiling of murine syngeneic tumor models as a framework to guide mechanistic studies and predict therapy response in distinct tumor microenvironments.
PLoS One
; 13(11): e0206223, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30388137
10.
Tipifarnib and bortezomib are synergistic and overcome cell adhesion-mediated drug resistance in multiple myeloma and acute myeloid leukemia.
Clin Cancer Res
; 12(2): 591-9, 2006 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-16428505
11.
Synergistic down-regulation of urokinase plasminogen activator receptor and matrix metalloproteinase-9 in SNB19 glioblastoma cells efficiently inhibits glioma cell invasion, angiogenesis, and tumor growth.
Cancer Res
; 63(10): 2454-61, 2003 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-12750266
12.
Adenovirus-mediated expression of antisense urokinase plasminogen activator receptor and antisense cathepsin B inhibits tumor growth, invasion, and angiogenesis in gliomas.
Cancer Res
; 64(12): 4069-77, 2004 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-15205313
13.
Inhibition of cathepsin B and MMP-9 gene expression in glioblastoma cell line via RNA interference reduces tumor cell invasion, tumor growth and angiogenesis.
Oncogene
; 23(27): 4681-9, 2004 Jun 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-15122332
14.
Blockade of cathepsin B expression in human glioblastoma cells is associated with suppression of angiogenesis.
Oncogene
; 23(12): 2224-30, 2004 Mar 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-14730346
15.
Activation of caspase-9 with irradiation inhibits invasion and angiogenesis in SNB19 human glioma cells.
Oncogene
; 23(13): 2339-46, 2004 Mar 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-14767475
16.
Modulation of invasive properties of human glioblastoma cells stably expressing amino-terminal fragment of urokinase-type plasminogen activator.
Oncogene
; 21(51): 7824-30, 2002 Nov 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-12420219
17.
Expression of antisense uPAR and antisense uPA from a bicistronic adenoviral construct inhibits glioma cell invasion, tumor growth, and angiogenesis.
Oncogene
; 22(38): 5967-75, 2003 Sep 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-12955075
18.
Modulation of cystatin C expression impairs the invasive and tumorigenic potential of human glioblastoma cells.
Oncogene
; 21(57): 8705-12, 2002 Dec 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-12483523
19.
Promoter methylation and silencing of the tissue factor pathway inhibitor-2 (TFPI-2), a gene encoding an inhibitor of matrix metalloproteinases in human glioma cells.
Oncogene
; 22(29): 4509-16, 2003 Jul 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-12881707
20.
Minimal and inducible regulation of tissue factor pathway inhibitor-2 in human gliomas.
Oncogene
; 21(6): 921-8, 2002 Jan 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-11840337